ADRB2 and neoplasm: Particularly, investigations in oral cancer cell lines have demonstrated that β2-AR signaling upregulates interleukin-6 (IL-6) mRNA, a cytokine that is involved in angiogenesis and tumor progression process, increasing proliferation and invasion of the tumor [16, 18].